Caveolin-3 is involved in the protection of resveratrol against high-fat-diet-induced insulin resistance by promoting GLUT4 translocation to the plasma membrane in skeletal muscle of ovariectomized rats

Journal of Nutritional Biochemistry

Volumn 23, Issue 12, 2012, Pages 1716-1724

  Tan, Zhi ^a   Zhou, Li Jun ^a   Mu, Pan Wei ^b   Liu, Shui Ping ^a   Chen, Si Juan ^a   Fu, Xiao Dong ^a   Wang, Ting Huai ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Caveolin 3; Estrogen receptor; GLUT4; High fat diet; Insulin resistance

Indexed keywords

CAVEOLIN 3; GLUCOSE TRANSPORTER 4; INSULIN; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIPID DIET; MYOTUBE; NONHUMAN; OVARIECTOMY; PROTEIN EXPRESSION; RAT; SOLEUS MUSCLE;

ANIMALS; CAVEOLIN 3; CELL MEMBRANE; DIET, HIGH-FAT; ESTROGEN RECEPTOR ALPHA; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RESISTANCE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OVARIECTOMY; PROTECTIVE AGENTS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

CHICKEN ANEMIA VIRUS; RATTUS; RICE STRIPE VIRUS;

EID: 84869081473     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.12.003     Document Type: Article

References (41)

1. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995, 75:473-486.
2. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339:1523-1526.
3. Petrovski G., Gurusamy N., Das D.K. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci 2011, 1215:22-33.
4. Penumathsa S.V., Thirunavukkarasu M., Zhan L., Maulik G., Menon V.P., Bagchi D., et al. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J Cell Mol Med 2008, 12:2350-2361.
5. Deng J.Y., Hsieh P.S., Huang J.P., Lu L.S., Hung L.M. Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways. Diabetes 2008, 57:1814-1823.
6. Bell G.I., Polonsky K.S. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 2001, 414:788-791.
7. Rea S., James D.E. Moving GLUT4: the biogenesis and trafficking of GLUT4 storage vesicles. Diabetes 1997, 46:1667-1677.
8. Thurmond D.C., Pessin J.E. Discrimination of GLUT4 vesicle trafficking from fusion using a temperature-sensitive Munc18c mutant. EMBO J 2000, 19:3565-3575.
9. Gustavsson J., Parpal S., Stralfors P. Insulin-stimulated glucose uptake involves the transition of glucose transporters to a caveolae-rich fraction within the plasma membrane: implications for type II diabetes. Mol Med 1996, 2:367-372.
10. Cohen A.W., Combs T.P., Scherer P.E., Lisanti M.P. Role of caveolin and caveolae in insulin signaling and diabetes. Am J Physiol Endocrinol Metab 2003, 285:E1151-E1160.
11. Karlsson M., Thorn H., Parpal S., Stralfors P., Gustavsson J. Insulin induces translocation of glucose transporter GLUT4 to plasma membrane caveolae in adipocytes. FASEB J 2002, 16:249-251.
12. Cohen A.W., Hnasko R., Schubert W., Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiol Rev 2004, 84:1341-1379.
13. DeFronzo R.A., Jacot E., Jequier E., Maeder E., Wahren J., Felber J.P. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981, 30:1000-1007.
14. Capozza F., Combs T.P., Cohen A.W., Cho Y.R., Park S.Y., Schubert W., et al. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol 2005, 288:C1317-C1331.
15. Oshikawa J., Otsu K., Toya Y., Tsunematsu T., Hankins R., Kawabe J., et al. Insulin resistance in skeletal muscles of caveolin-3-null mice. Proc Natl Acad Sci U S A 2004, 101:12670-12675.
16. Mu P., Tan Z., Cui Y., Liu H., Xu X., Huang Q., et al. 17beta-Estradiol attenuates diet-induced insulin resistance and glucose intolerance through up-regulation of caveolin-3. Ir J Med Sci 2011, 180:221-227.
17. Bowers J.L., Tyulmenkov V.V., Jernigan S.C., Klinge C.M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 2000, 141:3657-3667.
18. Bryant N.J., Govers R., James D.E. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 2002, 3:267-277.
19. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 2006, 116:1793-1801.
20. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
21. Ng S.F., Lin R.C., Laybutt D.R., Barres R., Owens J.A., Morris M.J. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 2010, 467:963-966.
22. Davies M.J., Baer D.J., Judd J.T., Brown E.D., Campbell W.S., Taylor P.R. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA 2002, 287:2559-2562.
23. Juntunen K.S., Laaksonen D.E., Poutanen K.S., Niskanen L.K., Mykkanen H.M. High-fiber rye bread and insulin secretion and sensitivity in healthy postmenopausal women. Am J Clin Nutr 2003, 77:385-391.
24. Barrett-Connor E., Schrott H.G., Greendale G., Kritz-Silverstein D., Espeland M.A., Stern M.P., et al. Factors associated with glucose and insulin levels in healthy postmenopausal women. Diabetes Care 1996, 19:333-340.
25. Rachon D., Vortherms T., Seidlova-Wuttke D., Wuttke W. Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats. Menopause 2007, 14:925-932.
26. Brasnyo P., Molnar G.A., Mohas M., Marko L., Laczy B., Cseh J., et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 2011, 1-7.
27. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
28. Barros R.P., Machado U.F., Gustafsson J.A. Estrogen receptors: new players in diabetes mellitus. Trends Mol Med 2006, 12:425-431.
29. Le M.C., Chu K., Hu M., Ortega C.S., Simpson E.R., Korach K.S., et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A 2006, 103:9232-9237.
30. Foryst-Ludwig A., Kintscher U. Metabolic impact of estrogen signalling through ERalpha and ERbeta. J Steroid Biochem Mol Biol 2010, 122:74-81.
31. Rossi R., Origliani G., Modena M.G. Transdermal 17-beta-estradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women. Diabetes Care 2004, 27:645-649.
32. Gehm B.D., McAndrews J.M., Chien P.Y., Jameson J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A 1997, 94:14138-14143.
33. Prossnitz E.R., Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol 2009, 308:32-38.
34. Riant E., Waget A., Cogo H., Arnal J.F., Burcelin R., Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009, 150:2109-2117.
35. Gorres B.K., Bomhoff G.L., Gupte A.A., Geiger P.C. Altered estrogen receptor expression in skeletal muscle and adipose tissue of female rats fed a high-fat diet. J Appl Physiol 2011, 110:1046-1053.
36. Bickel P.E. Lipid rafts and insulin signaling. Am J Physiol Endocrinol Metab 2002, 282:E1-E10.
37. Ishikawa Y., Otsu K., Oshikawa J. Caveolin; different roles for insulin signal?. Cell Signal 2005, 17:1175-1182.
38. Karlsson M., Thorn H., Parpal S., Stralfors P., Gustavsson J. Insulin induces translocation of glucose transporter Glut-4 to plasma membrane caveolae in adipocytes. FASEB J 2002, 16:249-251.
39. Fecchi K., Volonte D., Hezel M.P., Schmeck K., Galbiati F. Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells. FASEB J 2006, 20:705-707.
40. Oh Y.S., Cho K.A., Ryu S.J., Khil L.Y., Jun H.S., Yoon J.W., et al. Regulation of insulin response in skeletal muscle cell by caveolin status. J Cell Biochem 2006, 99:747-758.
41. Tsutsumi Y.M., Kawaraguchi Y., Horikawa Y.T., Niesman I.R., Kidd M.W., Chin-Lee B., et al. Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection. Anesthesiology 2010, 112:1136-1145.